Valerio Therapeutics Provides an Update on Its Business and Presents Its Financial Results for the First Half of 2026
For best results when printing this announcement, please click on link below: Valerio Therapeutics Provides an Update on Its Business and Presents Its Financial Results for the First Half of 2026 Operational launch of InVimmune, a subsidiary dedicated to differentiated approaches to in vivo cell therapy, with a first i